Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Childhood Cancer Patients’ Treatments May Lead To Later Emotional Problems.

HealthDay (5/30, Preidt) reports, “Adult survivors of childhood cancer can suffer emotional problems and reduced quality of life because of the long-term physical effects of their cancer treatment,” according to a study published in the Journal of Clinical Oncology. Investigators looked at “data from the Childhood Cancer Survivor Study to assess the effects of scarring, disfigurement and persistent hair loss experienced by more than 14,000 adult survivors of childhood cancer.” The researchers found that “survivors with persistent hair loss had an increased risk of anxiety; female survivors with persistent hair loss had an increased risk of depressive symptoms; and survivors with a head or neck, arm or leg disfigurement had an increased risk of depression.”

Related Links:

— “Emotional Woes May Last for Childhood Cancer Survivors,”Robert Preidt, HealthDay, May 30, 2012.

Screening Tool To Help Determine Emotional Health Risk.

USA Today (5/30, Healy) reports on screening tool Whats MyM3, which “can tell if you’re at increased risk for depression, anxiety disorder, bipolar disorder and post-traumatic stress disorder (PTSD).” Psychiatrist Steven Daviss, MD, of M3 Information, said that “WhatsMyM3 (originally My Mood Monitor) can help adults, whether in treatment or not, ‘monitor their own symptoms and have a view of what’s going on’ in terms of mood and anxiety.” Psychiatrist Robert Post, MD, former chief of biological psychiatry at the National Institute of Mental Health and one of the WhatsMyM3 developers, added that “many of those in need of treatment are seen in a primary care setting; yet their emotional health ‘never really comes up for discussion’ and goes untreated.”

Related Links:

— “Screening for mental illness? Yes, there’s an app for that,”Michelle Healy, USA Today, May 30, 2012.

FDA Warns Of Fake AD/HD Medication Tablets.

The Wall Street Journal (5/30, Rockoff, Dooren, Subscription Publication) reports that the Food and Drug Administration is warning that a fake version of Adderall (amphetamine, dextroamphetamine mixed salts) is being sold on the Internet.
The AP (5/30) reports that the agency “says the product purports to be 30-milligram Adderall tablets, but it does not contain the right ingredients. The pills contain the pain drugs tramadol and acetaminophen instead.”
The Boston Globe (5/30, Kotz) reports that the agency, in a media statement, said, “Consumers should be extra cautious when buying their medicines from online sources.” According to the FDA, “Rogue websites and distributors may especially target medicines in short supply for counterfeiting.”

The Los Angeles Times (5/30, Maugh) “Booster Shots” blog reports, “The phony medication can be easily detected. The package label contains several misspellings: ‘NDS’ instead of ‘NDC,’ ‘Aspartrte’ instead of ‘Aspartate,’ and ‘Singel’ instead of ‘Single.'”

Additionally, the NPR (5/30, Knox) “Shots” blog reports, the fake pills are “white instead of peachy-pink. They’re smooth, with none of the markings of the real 30-milligram tablets — the highest dose.” Meanwhile, “they may come in blister packs, while real Adderall is sold only in 100-count bottles.” Reuters (5/30, Yukhananov) also covers the story.

Related Links:

— “FDA Warns About Fakes of ADHD Drug Adderall,”Jonathan D. Rockoff , The Wall Street Journal, May 29, 2012.

Maternal Antidepressant Use Associated With Earlier Birth, Neonate Seizures.

Reuters (5/31, Norton) reports that according to a study published online May 2 in the American Journal of Obstetrics & Gynecology, babies born to mothers on antidepressants may be born a few days earlier or may even have seizures shortly after being born. After examining data on some 228,876 babies born in Tennessee, researchers found that second-trimester maternal antidepressant use was associated with infants being born up to five days before their due date. Maternal third-trimester use of selective serotonin reuptake inhibitor antidepressants was associated with neonate seizures. Because depression itself is a serious problem, the study authors recommended that women who are on medications for depression speak to their physicians about whether they should discontinue taking antidepressants during pregnancy.

Related Links:

— “More questions on antidepressants during pregnancy,”Amy Norton, Reuters, May 30, 2012.

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.